2m 2m 2m 2m 2m 2m 2m
Aldeyra Therapeu (ALDX)
NASDAQ
$1.95+$0.02 (+1.04%)
Price as of Jul 14, 2026 5:17 AM EDT- $116.4MMarket Cap
- -61.48%1-Year Change
- BiotechnologyIndustry
Aldeyra Therapeu (ALDX)
$1.95+$0.02 (+1.04%)
ALDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.93 | ||
Change | -$0.14 (-6.76%) | ||
Open | $2.03 | ||
High | $2.06 | ||
Low | $1.90 | ||
Previous Close | $2.07 | ||
Volume | 1,377,465 | ||
30-Day Average Volume | 2,115,606 | ||
1-Week Change | -15.35% | ||
1-Month Change | 9.66% | ||
1-Year Change | -61.48% | ||
3-Year Change | -75.22% | ||
5-Year Change | -80.83% | ||
Fundamentals | |||
Shares Outstanding | 60.3M | ||
Total Assets | $66.5M | ||
Market Cap | $116.4M | ||
Enterprise Value | $66.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.5M | ||
Free Cash Flow | -$5.1M | ||
EBIT | -$3.5M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $41.9M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -32 | ||
PEG | -1 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue